Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer

Clinical trial NCT00669565 · COMPLETED

Trial details

NCT number: NCT00669565
Sponsor: Peregrine Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma Breast Stage IV

Start date: 2008-07-01
Primary completion: 2010-07-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.